Back

No Feature content logo

Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies - Webinar

Posted by William T.
FDA CDER Small Business and Industry Assistance (SBIA)

15 days ago

This webinar will discuss the final guidance for the industry Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies which was published in July 2024. 

Our FDA subject matter experts will also address recommendations from the guidance including, deciding whether and when to conduct the study, as well as how to design and report results from a human radiolabeled mass balance study. 

Earn 1.0 CME/CPE/CNE!

Register here ➡️ Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies - 11/12/2024 | FDA⁠⁠⁠⁠⁠⁠⁠

Show More
Get Your Copy
Please fill out the required information.

First Name is required.
Last Name is required.
Business Email is required.
Company Name is required.